Total (N = 155)
Pregnant COVID-19 patients (n = 31) Non-Pregnant COVID-19 patients (n = 124)
P Value
ICU admission 5 (3.2%) 0 5 (4.0%) .584
Complications
ARDS 1 (0.6%) 0 1 (0.8%) 1.000
Acute kidney injury 1 (0.6%) 0 1 (0.8%) 1.000
Acute liver injury 4 (2.6%) 0 4 (3.2%) .584
Urinary tract infection 2 (1.3%) 1 (3.2%) 1 (0.8%) .361
Treatments
Antiviral therapy 132 (85.2%) 27 (87.1%) 105 (84.7%) .955
Antibiotic therapy 94 (60.6%) 27 (87.1%) 67 (54.0%) .001
Corticosteroid 43 (27.7%) 23 (74.2%) 20 (16.1%) <.001
Immunoglobulin 32 (20.6%) 5 (16.1%) 27 (21.8%) .487
Continuous renal replacement therapy 1 (0.6%) 0 1 (0.8%) 1.000
Oxygen support 56 (36.1%) 22 (71.0%) 34 (27.4%) <.001
Mask and Nasal cannula 53 (34.2%) 22 (71.0%) 31 (25.0%)
Non-invasive ventilation or high-flow nasal cannula 2 (1.3%) 0 2 (1.6%)
Invasive mechanical ventilation 0 0 0
Invasive mechanical ventilation and ECMO 1 (0.6%) 0 1 (0.8%)
Clinical outcomes
Hospital stays, days 9 (8.0, 17.0) 13 (9.0, 24.0) 9.0 (8.0, 15.8) .062
Discharge 155 (100.0%) 31 (100.0%) 124 (100.0%)